- Corporate Officers - H
- Hastings David C
Insider Trading History of Hastings David C
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hastings David C since 2006.
This trader's CIK number is 1237401.
At the time of last reporting, Hastings David C was the Chief Financial Officer of Arbutus Biopharma Corp. (stock ticker symbol ABUS).
Also see all insider trading activities at Arbutus Biopharma Corp.
Note that in the past
HASTINGS DAVID C also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Incyte Corp (INCY) by Hastings David C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | INCY | 0 | $0 | 475,000 | $28,659,230 | 475,000 | $5,275,100 |
| 2013 | INCY | 0 | $0 | 200,000 | $5,767,999 | 200,000 | $1,471,200 |
| 2011 | INCY | 0 | $0 | 100,000 | $1,773,500 | 100,000 | $512,000 |
| 2010 | INCY | 2,000 | $20,480 | 0 | $0 | 0 | $0 |
| 2008 | INCY | 4,000 | $9,440 | 0 | $0 | 0 | $0 |
| 2006 | INCY | 2,500 | $9,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Arbutus Biopharma Corp (ABUS) by Hastings David C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ABUS | 0 | $0 | 22,183 | $72,826 | 0 | $0 |
| 2024 | ABUS | 0 | $0 | 9,593 | $22,188 | 0 | $0 |
Yearly summary of insider trading at Scynexis Inc (SCYX) by Hastings David C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | SCYX | 11,834 | $19,999 | 0 | $0 | 0 | $0 |
| 2017 | SCYX | 20,000 | $35,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Hastings David C:
1. Incyte Corp (INCY)
2. Arbutus Biopharma Corp (ABUS)
3. Scynexis Inc (SCYX)
Table 1. Insider trading of Incyte Corp (INCY) by Hastings David C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-06-05 | INCY | Sale | 123,966 | 52.81 | 6,546,644 |
| 2014-06-04 | INCY | Sale | 76,034 | 52.61 | 4,000,148 |
| 2014-06-05 | INCY | Option Ex | 123,966 | 5.99 | 742,928 |
| 2014-06-04 | INCY | Option Ex | 76,034 | 13.81 | 1,050,409 |
| 2014-02-14 | INCY | Option Ex | 40,000 | 8.99 | 359,600 |
| 2014-02-13 | INCY | Sale | 202,999 | 66.12 | 13,422,293 |
| 2014-02-14 | INCY | Sale | 40,000 | 64.74 | 2,589,600 |
| 2014-02-18 | INCY | Option Ex | 32,001 | 8.99 | 287,688 |
| 2014-02-18 | INCY | Sale | 32,001 | 65.64 | 2,100,545 |
| 2014-02-13 | INCY | Option Ex | 202,999 | 13.96 | 2,834,475 |
| 2013-09-06 | INCY | Option Ex | 100,000 | 7.09 | 709,000 |
| 2013-09-06 | INCY | Sale | 100,000 | 35.16 | 3,515,999 |
| 2013-02-15 | INCY | Sale | 100,000 | 22.52 | 2,252,000 |
| 2013-02-15 | INCY | Option Ex | 100,000 | 7.62 | 762,200 |
| 2011-06-09 | INCY | Option Ex | 100,000 | 5.12 | 512,000 |
| 2011-06-09 | INCY | Sale | 100,000 | 17.73 | 1,773,500 |
| 2010-07-01 | INCY | Buy | 2,000 | 10.24 | 20,480 |
| 2008-11-20 | INCY | Buy | 4,000 | 2.36 | 9,440 |
| 2006-04-04 | INCY | Buy | 2,500 | 3.60 | 9,000 |
Table 2. Insider trading of Arbutus Biopharma Corp (ABUS) by Hastings David C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-04 | ABUS | Sale | 22,183 | 3.28 | 72,826 |
| 2024-02-02 | ABUS | Sale | 9,593 | 2.31 | 22,188 |
Table 3. Insider trading of Scynexis Inc (SCYX) by Hastings David C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-03-08 | SCYX | Buy | 11,834 | 1.69 | 19,999 |
| 2017-06-21 | SCYX | Buy | 20,000 | 1.75 | 35,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hastings David C
(Chief Financial Officer of Arbutus Biopharma Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.